Verastem Announces Initiation of COMMAND Study in Japan

[Business Wire] – CAMBRIDGE, Mass.–(BUSINESSWIRE)– Verastem, Inc. (NASDAQ:VSTM – News), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced the expansion of its ongoing COMMAND study more

View todays social media effects on VSTM

View the latest stocks trending across Twitter. Click to view dashboard

See who Verastem is hiring next, click here to view